Align Technology surpassed financial analysts’ expectations for first-quarter earnings on April 29, driven by robust sales of its dental alignment products, while simultaneously unveiling a $200 million stock repurchase initiative that pushed shares higher by up to 4% during extended trading hours.
Industry experts anticipate the dental market will find stability by 2026, though they maintain a reserved outlook regarding complete recovery following last year’s turbulent period characterized by inconsistent patient appointments that has made investors wary.
The company behind Invisalign reported minimal effects from Middle Eastern conflicts during the first quarter, although healthcare providers in that region have observed some reduction in patient visits and treatment acceptance rates.
“Overall, we think this is a much better than expected print and like that many of the underlying longer-term growth drivers are beginning to bear fruit,” said Evercore ISI analyst Elizabeth Anderson.
The manufacturer of dental retainers, oral scanning equipment, and laboratory software projects second-quarter revenues between $1.04 billion and $1.06 billion, closely matching analyst projections of $1.06 billion based on LSEG data compilation.
Company leadership also maintained their annual forecast of 3% to 4% revenue expansion and mid-single digit volume increases for their primary Clear Aligner product line.
For the quarter concluding March 31, Align reported adjusted earnings of $2.58 per share with revenues reaching $1.04 billion, surpassing analyst predictions of $2.28 per share profit and $1.02 billion in sales.
